# Worthington Enterprises, Inc.: financial statements, quarterly

WOR · NYSE · CIK 108516 · [Materials](/sectors/materials.md) · fiscal year ends May 31

Pages: [Overview](/companies/wor.md) · [Financials](/companies/wor/financials.md) · [Filings](/companies/wor/filings.md) · [Insiders](/companies/wor/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/wor/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2024 (2023-11-30) | Q3 FY2024 (2024-02-29) | Q4 FY2024 (2024-05-31) | Q1 FY2025 (2024-08-31) | Q2 FY2025 (2024-11-30) | Q3 FY2025 (2025-02-28) | Q4 FY2025 (2025-05-31) | Q1 FY2026 (2025-08-31) | Q2 FY2026 (2025-11-30) | Q3 FY2026 (2026-02-28) | Q4 FY2026 (2026-05-31) | Q1 FY2027 (2026-08-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,087](/filings/0000950170-24-003302.md) | [317](/filings/0000950170-25-052413.md) | [319 d](/filings/0001193125-26-325872.md) | [257](/filings/0001193125-25-234399.md) | [274](/filings/0001193125-26-008430.md) | [305](/filings/0001193125-26-149137.md) | [318 d](/filings/0001193125-26-325872.md) | [304](/filings/0001193125-26-418645.md) | [327](/filings/0001193125-26-008430.md) | [379](/filings/0001193125-26-149137.md) | [371 d](/filings/0001193125-26-325872.md) | [344](/filings/0001193125-26-418645.md) |
| Cost of revenue | $m | [235](/filings/0000950170-25-004028.md) | [244](/filings/0000950170-25-052413.md) | [240 d](/filings/0001193125-26-325872.md) | [195](/filings/0001193125-25-234399.md) | [200](/filings/0001193125-26-008430.md) | [215](/filings/0001193125-26-149137.md) | [225 d](/filings/0001193125-26-325872.md) | [221](/filings/0001193125-26-418645.md) | [243](/filings/0001193125-26-008430.md) | [269](/filings/0001193125-26-149137.md) | [270 d](/filings/0001193125-26-325872.md) | [253](/filings/0001193125-26-418645.md) |
| Gross profit | $m | [63.3](/filings/0000950170-25-004028.md) | [73.1](/filings/0000950170-25-052413.md) | [79.0 d](/filings/0001193125-26-325872.md) | [62.5](/filings/0001193125-25-234399.md) | [74.1](/filings/0001193125-26-008430.md) | [89.2](/filings/0001193125-26-149137.md) | [93.2 d](/filings/0001193125-26-325872.md) | [82.3](/filings/0001193125-26-418645.md) | [84.6](/filings/0001193125-26-008430.md) | [109](/filings/0001193125-26-149137.md) | [102 d](/filings/0001193125-26-325872.md) | [90.9](/filings/0001193125-26-418645.md) |
| Selling, general and administrative | $m | [70.6](/filings/0000950170-25-004028.md) | [65.1](/filings/0000950170-25-052413.md) | [73.2 d](/filings/0001193125-26-325872.md) | [66.0](/filings/0001193125-25-234399.md) | [67.9](/filings/0001193125-26-008430.md) | [63.0](/filings/0001193125-26-149137.md) | [71.5 d](/filings/0001193125-26-325872.md) | [70.6](/filings/0001193125-26-418645.md) | [70.7](/filings/0001193125-26-008430.md) | [75.7](/filings/0001193125-26-149137.md) | [77.9 d](/filings/0001193125-26-325872.md) | [77.2](/filings/0001193125-26-418645.md) |
| Operating income | $m | [(14.4)](/filings/0000950170-25-004028.md) | [4.3](/filings/0000950170-25-052413.md) | [(56.0) d](/filings/0001193125-26-325872.md) | [(4.7)](/filings/0001193125-25-234399.md) | [3.5](/filings/0001193125-26-008430.md) | [20.9](/filings/0001193125-26-149137.md) | [(30.4) d](/filings/0001193125-26-325872.md) | [9.2](/filings/0001193125-26-418645.md) | [12.3](/filings/0001193125-26-008430.md) | [31.5](/filings/0001193125-26-149137.md) | [23.2 d](/filings/0001193125-26-325872.md) | [13.0](/filings/0001193125-26-418645.md) |
| Interest expense | $m | [0.5](/filings/0000950170-25-004028.md) | [0.1](/filings/0000950170-25-052413.md) | [(0.0) d](/filings/0001193125-26-325872.md) | [0.5](/filings/0001193125-25-234399.md) | [1.0](/filings/0001193125-26-008430.md) | [0.6](/filings/0001193125-26-149137.md) | [(0.1) d](/filings/0001193125-26-325872.md) | [0.1](/filings/0001193125-26-418645.md) | [1.5](/filings/0001193125-26-008430.md) | [1.8](/filings/0001193125-26-149137.md) | [2.9 d](/filings/0001193125-26-325872.md) | [2.1](/filings/0001193125-26-418645.md) |
| Income tax | $m | [6.6](/filings/0000950170-25-004028.md) | [18.5](/filings/0000950170-25-052413.md) | [5.0 d](/filings/0001193125-26-325872.md) | [6.8](/filings/0001193125-25-234399.md) | [9.1](/filings/0001193125-26-008430.md) | [13.2](/filings/0001193125-26-149137.md) | [4.7 d](/filings/0001193125-26-325872.md) | [10.9](/filings/0001193125-26-418645.md) | [8.8](/filings/0001193125-26-008430.md) | [15.0](/filings/0001193125-26-149137.md) | [11.7 d](/filings/0001193125-26-325872.md) | [13.0](/filings/0001193125-26-418645.md) |
| Net income | $m | [24.3](/filings/0000950170-25-004028.md) | [22.0](/filings/0000950170-25-052413.md) | [(31.8) d](/filings/0001193125-26-325872.md) | [24.3](/filings/0001193125-25-234399.md) | [28.3](/filings/0001193125-26-008430.md) | [39.7](/filings/0001193125-26-149137.md) | [3.9 d](/filings/0001193125-26-325872.md) | [35.1](/filings/0001193125-26-418645.md) | [27.3](/filings/0001193125-26-008430.md) | [45.5](/filings/0001193125-26-149137.md) | [48.1 d](/filings/0001193125-26-325872.md) | [42.6](/filings/0001193125-26-418645.md) |
| Diluted EPS | $ per share | [0.49](/filings/0000950170-25-004028.md) | [0.44](/filings/0000950170-25-052413.md) | not reported | [0.48](/filings/0001193125-25-234399.md) | [0.56](/filings/0001193125-26-008430.md) | [0.79](/filings/0001193125-26-149137.md) | not reported | [0.70](/filings/0001193125-26-418645.md) | [0.55](/filings/0001193125-26-008430.md) | [0.92](/filings/0001193125-26-149137.md) | not reported | [0.87](/filings/0001193125-26-418645.md) |
| Basic EPS | $ per share | [0.49](/filings/0000950170-25-004028.md) | [0.45](/filings/0000950170-25-052413.md) | not reported | [0.49](/filings/0001193125-25-234399.md) | [0.57](/filings/0001193125-26-008430.md) | [0.80](/filings/0001193125-26-149137.md) | not reported | [0.71](/filings/0001193125-26-418645.md) | [0.56](/filings/0001193125-26-008430.md) | [0.93](/filings/0001193125-26-149137.md) | not reported | [0.88](/filings/0001193125-26-418645.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q2 FY2024 (2023-11-30) | Q3 FY2024 (2024-02-29) | FY2024 (2024-05-31) | Q1 FY2025 (2024-08-31) | Q2 FY2025 (2024-11-30) | Q3 FY2025 (2025-02-28) | FY2025 (2025-05-31) | Q1 FY2026 (2025-08-31) | Q2 FY2026 (2025-11-30) | Q3 FY2026 (2026-02-28) | FY2026 (2026-05-31) | Q1 FY2027 (2026-08-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [431](/filings/0000950170-24-003302.md) | [227](/filings/0000950170-24-042963.md) | [244](/filings/0000950170-25-100137.md) | [179](/filings/0000950170-24-113225.md) | [194](/filings/0000950170-25-004028.md) | [223](/filings/0000950170-25-052413.md) | [250](/filings/0001193125-26-325872.md) | [167](/filings/0001193125-25-234399.md) | [180](/filings/0001193125-26-008430.md) | [6.0](/filings/0001193125-26-149137.md) | [27.7](/filings/0001193125-26-418645.md) | [55.1](/filings/0001193125-26-418645.md) |
| Current assets | $m | [1,773](/filings/0000950170-24-003302.md) | [691](/filings/0000950170-24-042963.md) | [674](/filings/0000950170-25-100137.md) | [576](/filings/0000950170-24-113225.md) | [603](/filings/0000950170-25-004028.md) | [634](/filings/0000950170-25-052413.md) | [685](/filings/0001193125-26-325872.md) | [626](/filings/0001193125-25-234399.md) | [649](/filings/0001193125-26-008430.md) | [504](/filings/0001193125-26-149137.md) | [524](/filings/0001193125-26-418645.md) | [523](/filings/0001193125-26-418645.md) |
| Total assets | $m | [3,584](/filings/0000950170-24-003302.md) | [1,705](/filings/0000950170-24-042963.md) | [1,639](/filings/0000950170-25-100137.md) | [1,645](/filings/0000950170-24-113225.md) | [1,657](/filings/0000950170-25-004028.md) | [1,682](/filings/0000950170-25-052413.md) | [1,695](/filings/0001193125-26-325872.md) | [1,738](/filings/0001193125-25-234399.md) | [1,753](/filings/0001193125-26-008430.md) | [1,824](/filings/0001193125-26-149137.md) | [1,848](/filings/0001193125-26-418645.md) | [1,841](/filings/0001193125-26-418645.md) |
| Current liabilities | $m | [945](/filings/0000950170-24-003302.md) | [202](/filings/0000950170-24-042963.md) | [178](/filings/0000950170-25-100137.md) | [166](/filings/0000950170-24-113225.md) | [169](/filings/0000950170-25-004028.md) | [180](/filings/0000950170-25-052413.md) | [197](/filings/0001193125-26-325872.md) | [190](/filings/0001193125-25-234399.md) | [199](/filings/0001193125-26-008430.md) | [213](/filings/0001193125-26-149137.md) | [221](/filings/0001193125-26-418645.md) | [196](/filings/0001193125-26-418645.md) |
| Total liabilities | $m | [1,660](/filings/0000950170-24-003302.md) | [790](/filings/0000950170-24-042963.md) | [748](/filings/0000950170-25-100137.md) | [742](/filings/0000950170-24-113225.md) | [744](/filings/0000950170-25-004028.md) | [743](/filings/0000950170-25-052413.md) | [757](/filings/0001193125-26-325872.md) | [778](/filings/0001193125-25-234399.md) | [790](/filings/0001193125-26-008430.md) | [821](/filings/0001193125-26-149137.md) | [821](/filings/0001193125-26-418645.md) | [794](/filings/0001193125-26-418645.md) |
| Long-term debt | $m | [299](/filings/0000950170-24-003302.md) | [298](/filings/0000950170-24-042963.md) | [298](/filings/0000950170-25-100137.md) | [300](/filings/0000950170-24-113225.md) | [296](/filings/0000950170-25-004028.md) | [294](/filings/0000950170-25-052413.md) | [303](/filings/0001193125-26-325872.md) | [306](/filings/0001193125-25-234399.md) | [305](/filings/0001193125-26-008430.md) | [307](/filings/0001193125-26-149137.md) | [306](/filings/0001193125-26-418645.md) | [306](/filings/0001193125-26-418645.md) |
| Current portion of debt | $m | [150](/filings/0000950170-24-003302.md) | [0.3](/filings/0000950170-24-042963.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $m | [175](/filings/0000950170-24-003302.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [4.8](/filings/0001193125-26-149137.md) | not reported | not reported |
| Shareholders' equity | $m | [1,793](/filings/0000950170-24-003302.md) | [912](/filings/0000950170-24-042963.md) | [889](/filings/0000950170-25-100137.md) | [901](/filings/0000950170-24-113225.md) | [911](/filings/0000950170-25-004028.md) | [937](/filings/0000950170-25-052413.md) | [937](/filings/0001193125-26-325872.md) | [959](/filings/0001193125-25-234399.md) | [963](/filings/0001193125-26-008430.md) | [1,002](/filings/0001193125-26-149137.md) | [1,027](/filings/0001193125-26-418645.md) | [1,047](/filings/0001193125-26-418645.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q2 FY2024 (2023-11-30) | Q3 FY2024 (2024-02-29) | Q4 FY2024 (2024-05-31) | Q1 FY2025 (2024-08-31) | Q2 FY2025 (2024-11-30) | Q3 FY2025 (2025-02-28) | Q4 FY2025 (2025-05-31) | Q1 FY2026 (2025-08-31) | Q2 FY2026 (2025-11-30) | Q3 FY2026 (2026-02-28) | Q4 FY2026 (2026-05-31) | Q1 FY2027 (2026-08-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [135](/filings/0000950170-25-004028.md) | [50.1](/filings/0000950170-25-052413.md) | [45.2 d](/filings/0001193125-26-325872.md) | [41.1](/filings/0001193125-25-234399.md) | [49.1](/filings/0001193125-26-008430.md) | [57.1](/filings/0001193125-26-149137.md) | [62.4 d](/filings/0001193125-26-325872.md) | [41.1](/filings/0001193125-26-418645.md) | [51.5](/filings/0001193125-26-008430.md) | [61.9](/filings/0001193125-26-149137.md) | [71.6 d](/filings/0001193125-26-325872.md) | [66.7](/filings/0001193125-26-418645.md) |
| Capital expenditure | $m | [32.9](/filings/0000950170-25-004028.md) | [10.0](/filings/0000950170-25-052413.md) | [11.3 d](/filings/0001193125-26-325872.md) | [9.6](/filings/0001193125-25-234399.md) | [15.2](/filings/0001193125-26-008430.md) | [12.7](/filings/0001193125-26-149137.md) | [13.1 d](/filings/0001193125-26-325872.md) | [13.2](/filings/0001193125-26-418645.md) | [12.4](/filings/0001193125-26-008430.md) | [13.8](/filings/0001193125-26-149137.md) | [16.5 d](/filings/0001193125-26-325872.md) | [12.8](/filings/0001193125-26-418645.md) |
| Dividends paid | $m | [17.3](/filings/0000950170-25-004028.md) | [15.8](/filings/0000950170-25-052413.md) | [7.9 d](/filings/0001193125-26-325872.md) | [8.1](/filings/0001193125-25-234399.md) | [9.0](/filings/0001193125-26-008430.md) | [8.4](/filings/0001193125-26-149137.md) | [8.4 d](/filings/0001193125-26-325872.md) | [8.6](/filings/0001193125-26-418645.md) | [9.6](/filings/0001193125-26-008430.md) | [9.3](/filings/0001193125-26-149137.md) | [9.4 d](/filings/0001193125-26-325872.md) | [9.4](/filings/0001193125-26-418645.md) |
| Share repurchases | $m | not reported | not reported | not reported | [6.8](/filings/0001193125-25-234399.md) | [8.1](/filings/0001193125-26-008430.md) | [6.2](/filings/0001193125-26-149137.md) | [9.8 d](/filings/0001193125-26-325872.md) | [6.3](/filings/0001193125-26-418645.md) | [13.7](/filings/0001193125-26-008430.md) | [5.4](/filings/0001193125-26-149137.md) | [18.4 d](/filings/0001193125-26-325872.md) | [18.2](/filings/0001193125-26-418645.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q2 FY2023 (2022-11-30) | Q3 FY2023 (2023-02-28) | Q1 FY2024 (2023-08-31) | Q2 FY2024 (2023-11-30) | Q3 FY2024 (2024-02-29) | Q1 FY2025 (2024-08-31) | Q2 FY2025 (2024-11-30) | Q3 FY2025 (2025-02-28) | Q1 FY2026 (2025-08-31) | Q2 FY2026 (2025-11-30) | Q3 FY2026 (2026-02-28) | Q1 FY2027 (2026-08-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [49.3](/filings/0000950170-24-003302.md) | [49.5](/filings/0000950170-24-042963.md) | [49.9](/filings/0000950170-24-113225.md) | [50.0](/filings/0000950170-25-004028.md) | [50.4](/filings/0000950170-25-052413.md) | [50.4](/filings/0001193125-25-234399.md) | [50.1](/filings/0001193125-26-008430.md) | [50.0](/filings/0001193125-26-149137.md) | [50.0](/filings/0001193125-26-418645.md) | [49.8](/filings/0001193125-26-008430.md) | [49.7](/filings/0001193125-26-149137.md) | [49.2](/filings/0001193125-26-418645.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 49,259,710 at 2026-10-05, from the cover of the [10-Q filed 2026-10-09](/filings/0001193125-26-418645.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:21 ET. No prices; not investment advice.